Document is current
Any future updates will be listed below
-
Authors
Viana, Iara G. R. https://orcid.org/0000-0002-7669-2539
Vireque, Alessandra A. https://orcid.org/0000-0002-2597-531X
Da Luz, Caroline M. https://orcid.org/0000-0001-6733-8266
Alberici, Luciane Carla https://orcid.org/0000-0002-7464-9385
Navarro, Paula A. https://orcid.org/0000-0003-2368-4188
-
Funding
Funding for this research was provided by:
FAEPA (No. 1312/2017)
INVITRA Assisted Reproductive Technologies Ltd. (No. 16.1.480.17.4)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 18 November 2025
First Online: 10 December 2025
Declarations
:
: All animal procedures were conducted in accordance with the Guidelines for Care and Use of Laboratory Animals, the ethical standards and principles of the National Council for Animal Control and Experimentation (CONCEA) and were approved by the Research Ethics Committee of the Department of Gynecology and Obstetrics of Ribeirão Preto Medical School (FMRP), University of São Paulo (USP), and the Institutional Ethics Committee on Animal Use (Protocol No. 233/2014).
: CML and LCA declare no financial relationships with any organizations that might have an interest in this study; AAV is the co-founder of Invitra; AAV and PAN and IGRV have a patent application for the use of l -carnitine and lipids as supplements in vitrification-warming media (BR 102019013697–9).
